Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

SANA Sana Biotechnology Inc

4,30

0,00 (0,00%)

09 Jan 2025 - Fermé

Retardé de 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Sana Biotechnology (NASDAQ:SANA)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025

Plus de graphiques de la Bourse Sana Biotechnology

Sana Biotechnology (NASDAQ:SANA)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025

Plus de graphiques de la Bourse Sana Biotechnology

Actualités Sana Biotechnology Inc

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Mercredi 8 Janvier 2025 ( il y a 16 heures) • GlobeNewswire Inc.

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Mardi 7 Janvier 2025 ( il y a 2 jours) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Lundi 16 Décembre 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus
Lundi 2 Décembre 2024 ( il y a 1 mois) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Mercredi 27 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lundi 25 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Sana Biotechnology to Present at December 2024 Investor Conferences
Lundi 25 Novembre 2024 ( il y a 1 mois) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Vendredi 8 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Vendredi 8 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates
Vendredi 8 Novembre 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025
Lundi 4 Novembre 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
Mercredi 23 Octobre 2024 ( il y a 3 mois) • PR Newswire (US)

Plus d'articles sur Sana Biotechnology Inc

Vontobel Financial Produ...

BNP Paribas Issuance

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales